These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 17209192

  • 1. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease.
    Catassi C, Fabiani E, Iacono G, D'Agate C, Francavilla R, Biagi F, Volta U, Accomando S, Picarelli A, De Vitis I, Pianelli G, Gesuita R, Carle F, Mandolesi A, Bearzi I, Fasano A.
    Am J Clin Nutr; 2007 Jan; 85(1):160-6. PubMed ID: 17209192
    [Abstract] [Full Text] [Related]

  • 2. Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge.
    Adriaanse MP, Leffler DA, Kelly CP, Schuppan D, Najarian RM, Goldsmith JD, Buurman WA, Vreugdenhil AC.
    Am J Gastroenterol; 2016 Jul; 111(7):1014-22. PubMed ID: 27185075
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease.
    Kurppa K, Paavola A, Collin P, Sievänen H, Laurila K, Huhtala H, Saavalainen P, Mäki M, Kaukinen K.
    Gastroenterology; 2014 Sep; 147(3):610-617.e1. PubMed ID: 24837306
    [Abstract] [Full Text] [Related]

  • 5. A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
    Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R, CEC-3 Trial Group.
    N Engl J Med; 2021 Jul 01; 385(1):35-45. PubMed ID: 34192430
    [Abstract] [Full Text] [Related]

  • 6. No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.
    Murray JA, Kelly CP, Green PHR, Marcantonio A, Wu TT, Mäki M, Adelman DC, CeliAction Study Group of Investigators.
    Gastroenterology; 2017 Mar 01; 152(4):787-798.e2. PubMed ID: 27864127
    [Abstract] [Full Text] [Related]

  • 7. Gluten tolerance in adult patients with celiac disease 20 years after diagnosis?
    Hopman EG, von Blomberg ME, Batstra MR, Morreau H, Dekker FW, Koning F, Lamers CB, Mearin ML.
    Eur J Gastroenterol Hepatol; 2008 May 01; 20(5):423-9. PubMed ID: 18403944
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.
    Tack GJ, van de Water JM, Bruins MJ, Kooy-Winkelaar EM, van Bergen J, Bonnet P, Vreugdenhil AC, Korponay-Szabo I, Edens L, von Blomberg BM, Schreurs MW, Mulder CJ, Koning F.
    World J Gastroenterol; 2013 Sep 21; 19(35):5837-47. PubMed ID: 24124328
    [Abstract] [Full Text] [Related]

  • 10. Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease.
    Lähdeaho ML, Mäki M, Laurila K, Huhtala H, Kaukinen K.
    BMC Gastroenterol; 2011 Nov 24; 11():129. PubMed ID: 22115041
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study.
    Lähdeaho ML, Scheinin M, Vuotikka P, Taavela J, Popp A, Laukkarinen J, Koffert J, Koivurova OP, Pesu M, Kivelä L, Lovró Z, Keisala J, Isola J, Parnes JR, Leon F, Mäki M.
    Lancet Gastroenterol Hepatol; 2019 Dec 24; 4(12):948-959. PubMed ID: 31494096
    [Abstract] [Full Text] [Related]

  • 12. Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients.
    Hollon JR, Cureton PA, Martin ML, Puppa EL, Fasano A.
    BMC Gastroenterol; 2013 Feb 28; 13():40. PubMed ID: 23448408
    [Abstract] [Full Text] [Related]

  • 13. Reintroduction of gluten following flour transamidation in adult celiac patients: a randomized, controlled clinical study.
    Mazzarella G, Salvati VM, Iaquinto G, Stefanile R, Capobianco F, Luongo D, Bergamo P, Maurano F, Giardullo N, Malamisura B, Rossi M.
    Clin Dev Immunol; 2012 Feb 28; 2012():329150. PubMed ID: 22899947
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease.
    Leffler D, Schuppan D, Pallav K, Najarian R, Goldsmith JD, Hansen J, Kabbani T, Dennis M, Kelly CP.
    Gut; 2013 Jul 28; 62(7):996-1004. PubMed ID: 22619366
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial.
    Leonard MM, Silvester JA, Leffler D, Fasano A, Kelly CP, Lewis SK, Goldsmith JD, Greenblatt E, Kwok WW, McAuliffe WJ, Galinsky K, Siegelman J, Chow IT, Wagner JA, Sapone A, Smithson G.
    Gastroenterology; 2021 Feb 28; 160(3):720-733.e8. PubMed ID: 33130104
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease.
    Cellier C, Cervoni JP, Patey N, Leborgne M, Marteau P, Landi B, Cerf-Bensussan N, Barbier JP, Brousse N.
    Am J Gastroenterol; 1998 Sep 28; 93(9):1527-30. PubMed ID: 9732937
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.